A real-world disproportionality analysis of colchicine: data mining of the public version of FDA Adverse Event Reporting System
Continuous monitoring is essential to detect established and emerging ADRs. These findings enhance understanding of colchicine's safety profile, with further research needed to validate these signals.
Authors
- Guilong Tian (ORCID: https://orcid.org/0000-0001-6386-4461)
- Zhiguo Dai (ORCID: https://orcid.org/0009-0008-4734-8115)
- Ye Xu (ORCID: https://orcid.org/0009-0005-7561-8678)
- HE Li-qun (ORCID: https://orcid.org/0000-0002-3431-8100)
Institutions
- Wuhan No.1 Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1080/14740338.2024.2442053
- Citations
- 1
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.40